300639.SZ
凯普生物
SZSE · Healthcare · C 制造业 · CN
CNY 5.97
−3.40%Margins
Gross margin
44.5%
EBITDA margin
2.3%
EBIT margin
-17.9%
Net margin
-16.1%
FCF margin
34.0%
-2.8%
Return on equity
-2.5%
Return on assets
-3.1%
Return on invested capital
0.16x
Asset turnover
CNY 319.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026